Related Experiment Video
Updated: Aug 16, 2026
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
[Therapy of heart failure. General practice references for individual treatment]
1fgoss@t-online.de
Insights
Effective treatment for cardiac insufficiency in older adults involves coordinated care and evidence-based medication. This approach reduces mortality and hospitalizations, improving quality of life for elderly patients.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacotherapy
Context:
- Cardiac insufficiency is the leading cause of hospitalization for individuals over 65.
- Associated healthcare costs are substantial, including drug expenses, hospital stays, and early retirement.
- Inadequate implementation of current therapeutic guidelines is noted, often due to budgetary constraints and rising costs.
Purpose:
- To highlight the necessity of close collaboration between family doctors and cardiologists.
- To emphasize the importance of rational, evidence-based, and cost-optimized treatment strategies for chronic heart failure.
- To advocate for improved pharmacotherapy in ambulatory patient care for elderly patients with multimorbidity.
Summary:
- Chronic heart failure is highly responsive to differentiated drug treatment.
- Optimal treatment with ACE inhibitors, beta-blockers, diuretics, aldosterone antagonists, and digitalis can decrease mortality and morbidity.
- This includes improving quality of life and reducing hospitalization duration.
Impact:
- Optimally adapted and adequately dosed pharmacotherapy significantly lowers mortality rates.
- Treatment leads to a substantial reduction in morbidity, enhancing patient quality of life.
- Individually adapted pharmacotherapy is crucial for elderly patients with multimorbidity in ambulatory care settings.
Abstract:
Cardiac insufficiency is today the most common reason for hospitalizing patients older than 65 years, and is associated with considerable costs for the health care system. The economic consequences (drug costs, hospitalization and costs of early retirement) necessitate close cooperation between family doctor and cardiologist if a rational (evidence based medicine) and cost-optimized treatment is to be achieved. The implementation of the current therapeutic concepts and guidelines issued by the specialist societies has so far been inadequate, in particular due to a misguided approach to budgeting, and the pressure of rising costs. Few diseases are as accessible to a differentiated drug treatment as chronic heart failure. Numerous studies have shown that an optimally adapted and adequately dosed treatment with ACE inhibitors, beta blockers, diuretics, aldosterone antagonists and digitalis is capable, not only of lowering the mortality rate, but also of achieving a significant reduction in morbidity (improved quality of life, shorter hospitalization). The treatment of the chronic forms of cardiac insufficiency is a domain of ambulatory patient care that, with an eye to the multimorbidity of the elderly, requires individually adapted pharmacotherapy.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
01:30Heart Failure IV: Classification and Diagnostic Evaluation
01:30Heart Failure V: Medical Management
01:22Heart Failure VI: Adjunct Therapies
01:30Heart Failure VII: Nursing Interventions
01:29Cardiomyopathy V: Interprofessional Care